We have discussed the expression NADPH oxidase in different models of glaucoma, highlighted the potential role of antioxidant therapy targeting NADPH oxidase and other enzymatic pathways in glaucoma, and identified prospective areas of research interest implicating NADPH oxidase in glaucoma. The gene discussed is FMO5; the disease is glaucoma.